by B2i | Apr 23, 2024 | Press Releases
GAITHERSBURG, Md., April 23, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (“RT”),...
by B2i | Apr 3, 2024 | Press Releases
Webcasted presentation to take place at 3:10pm ETGAITHERSBURG, Md., April 03, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients...
by B2i | Mar 22, 2024 | Press Releases
GAITHERSBURG, Md., March 22, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation...
by B2i | Mar 5, 2024 | Press Releases
Webcast presentation to take place at 11:25am ETROCKVILLE, Md., March 05, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients...
by B2i | Feb 13, 2024 | Press Releases
ROCKVILLE, Md., Feb. 13, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“SHPH” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients...
by B2i | Jan 23, 2024 | Press Releases
ROCKVILLE, Md., Jan. 23, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced...
